COMPANY
Fesarius Therapeutics
Timeline
- Grant Government grant — SBIR: $349,892 (annual award, as published), announced Jul 31, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗
Funding
- Government grant — SBIR: $349,892 (annual award, as published), announced Jul 31, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗
NIH awards 10
- NIH award 1R43GM156172-01 FY2024: $349,345 awarded for that fiscal year; activity R43 (SBIR); PI SAPIR LEKHOVITSER, YULIA; recipient as written: FESARIUSTHERAPEUTICS, INC., NEW YORK, NY. An advanced dermal regenerati source ↗
- NIH award 5SB1AR076301-05 FY2024: $396,663 awarded for that fiscal year; activity SB1 (SBIR); PI SAPIR LEKHOVITSER, YULIA; recipient as written: FESARIUSTHERAPEUTICS, INC., NEW YORK, NY. DermiSphere™: An Advanced Der source ↗
- NIH award 5R44AR082787-02 FY2024: $953,538 awarded for that fiscal year; activity R44 (SBIR); PI SAPIR LEKHOVITSER, YULIA; recipient as written: FESARIUSTHERAPEUTICS, INC., NEW YORK, NY. An Advanced Dermal Regenerati source ↗
- NIH award 3R44AR082787-01A1S1 FY2024: $50,000 awarded for that fiscal year; activity R44 (SBIR); PI SAPIR LEKHOVITSER, YULIA; recipient as written: FESARIUSTHERAPEUTICS, INC., NEW YORK, NY. An Advanced Dermal Regener source ↗
- NIH award 2SB1AR076301-04 FY2023: $399,734 awarded for that fiscal year; activity SB1 (SBIR); PI SAPIR LEKHOVITSER, YULIA; recipient as written: FESARIUSTHERAPEUTICS, INC., NEW YORK, NY. DermiSphere™: An Advanced Der source ↗
- NIH award 1R44AR082787-01A1 FY2023: $883,910 awarded for that fiscal year; activity R44 (SBIR); PI SAPIR LEKHOVITSER, YULIA; recipient as written: FESARIUSTHERAPEUTICS, INC., NEW YORK, NY. An Advanced Dermal Regenera source ↗
- NIH award 5R44AR076301-03 FY2021: $914,554 awarded for that fiscal year; activity R44 (SBIR); PI SAPIR LEKHOVITSER, YULIA; recipient as written: FESARIUSTHERAPEUTICS, INC., NEW YORK, NY. DermiSphere: An Advanced Derm source ↗
- NIH award 2R44AR076301-02 FY2020: $764,595 awarded for that fiscal year; activity R44 (SBIR); PI SAPIR LEKHOVITSER, YULIA; recipient as written: FESARIUSTHERAPEUTICS, INC., NEW YORK, NY. DermiSphereâÃÂâ: An A source ↗
- NIH award 3R43AR076301-01S1 FY2020: $55,000 awarded for that fiscal year; activity R43 (SBIR); PI SAPIR LEKHOVITSER, YULIA; recipient as written: FESARIUSTHERAPEUTICS, INC., NEW YORK, NY. FesariusTherapeutics Inc. I- source ↗
- NIH award 1R43AR076301-01 FY2019: $224,355 awarded for that fiscal year; activity R43 (SBIR); PI SAPIR LEKHOVITSER, YULIA; recipient as written: FESARIUSTHERAPEUTICS, INC., NEW YORK, NY. DermiSphere™: An Advanced Der source ↗
Connect
See your connections at Fesarius Therapeutics on LinkedIn (search by name, results not checked)